{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:40:26Z","timestamp":1792521626006,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05159-9","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:52:44Z","timestamp":1784865164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An incidental heterozygous ATP7B nonsense variant leading to a diagnostic pitfall for Wilson disease: a pediatric case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhongqiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"5159_CR1","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1002\/hep.32801","volume":"82","author":"ML Schilsky","year":"2025","unstructured":"Schilsky ML, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice guidance on wilson disease from the American association for the study of liver diseases. Hepatology. 2025;82:E41\u201390. https:\/\/doi.org\/10.1002\/hep.32801.","journal-title":"Hepatology"},{"key":"5159_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for Study of, L. EASL Clinical Practice Guidelines","year":"2012","unstructured":"European Association for Study of, L. EASL Clinical Practice Guidelines. Wilson\u2019s disease. J Hepatol. 2012;56:671\u201385. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.007.","journal-title":"J Hepatol"},{"key":"5159_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"P Ferenci","year":"2003","unstructured":"Ferenci P, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23:139\u201342. https:\/\/doi.org\/10.1034\/j.1600-0676.2003.00824.x.","journal-title":"Liver Int"},{"key":"5159_CR4","doi-asserted-by":"publisher","first-page":"e13147","DOI":"10.1111\/eci.13147","volume":"49","author":"AF Stattermayer","year":"2019","unstructured":"Stattermayer AF, et al. The dilemma to diagnose Wilson disease by genetic testing alone. Eur J Clin Invest. 2019;49:e13147. https:\/\/doi.org\/10.1111\/eci.13147.","journal-title":"Eur J Clin Invest"},{"key":"5159_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12041-010-0065-3","volume":"89","author":"G Gromadzka","year":"2010","unstructured":"Gromadzka G, et al. Middle-aged heterozygous carriers of Wilson\u2019s disease do not present with significant phenotypic deviations related to copper metabolism. J Genet. 2010;89:463\u20137. https:\/\/doi.org\/10.1007\/s12041-010-0065-3.","journal-title":"J Genet"},{"key":"5159_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12911-016-0377-1","volume":"16","author":"G Saposnik","year":"2016","unstructured":"Saposnik G, Redelmeier D, Ruff CC, Tobler PN. Cognitive biases associated with medical decisions: a systematic review. BMC Med Inf Decis Mak. 2016;16:138. https:\/\/doi.org\/10.1186\/s12911-016-0377-1.","journal-title":"BMC Med Inf Decis Mak"},{"key":"5159_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12881-018-0660-3","volume":"19","author":"C Collet","year":"2018","unstructured":"Collet C, et al. High genetic carrier frequency of Wilson\u2019s disease in France: discrepancies with clinical prevalence. BMC Med Genet. 2018;19:143. https:\/\/doi.org\/10.1186\/s12881-018-0660-3.","journal-title":"BMC Med Genet"},{"key":"5159_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.5603\/PJNNS.a2020.0063","volume":"54","author":"A Antos","year":"2020","unstructured":"Antos A, Litwin T, Skowronska M, Kurkowska-Jastrzebska I, Czlonkowska A. Pitfalls in diagnosing Wilson\u2019s Disease by genetic testing alone: the case of a 47-year-old woman with two pathogenic variants of the ATP7B gene. Neurol Neurochir Pol. 2020;54:478\u201380. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0063.","journal-title":"Neurol Neurochir Pol"},{"key":"5159_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Czlonkowska","year":"2018","unstructured":"Czlonkowska A, et al. Wilson disease. Nat Rev Dis Primers. 2018;4:21. https:\/\/doi.org\/10.1038\/s41572-018-0018-3.","journal-title":"Nat Rev Dis Primers"},{"key":"5159_CR10","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1212\/01.wnl.0000147298.05983.50","volume":"63","author":"MK Bruno","year":"2004","unstructured":"Bruno MK, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004;63:2280\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000147298.05983.50.","journal-title":"Neurology"},{"key":"5159_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/cpt.1004","volume":"103","author":"EJ Phillips","year":"2018","unstructured":"Phillips EJ, et al. Clinical Pharmacogenetics Implementation Consortium Guideline forHLAGenotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Clin Pharmacol Ther. 2018;103:574\u201381. https:\/\/doi.org\/10.1002\/cpt.1004.","journal-title":"Clin Pharmacol Ther"},{"key":"5159_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18433\/J36S7D","volume":"21","author":"W Tangamornsuksan","year":"2018","unstructured":"Tangamornsuksan W, Scholfield N, Lohitnavy M. Association Between HLA genotypes and Oxcarbazepine-induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-Analysis. J Pharm Pharm Sci. 2018;21:1\u201318. https:\/\/doi.org\/10.18433\/J36S7D.","journal-title":"J Pharm Pharm Sci"},{"key":"5159_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011;364:1126\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1009717.","journal-title":"N Engl J Med"},{"key":"5159_CR14","doi-asserted-by":"publisher","unstructured":"Tiwattanon K, et al. Implementation of HLA-B*15:02. Genotyping as standard-of-care for reducing carbamazepine\/oxcarbazepine induced cutaneous adverse drug reactions in Thailand. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.867490.","DOI":"10.3389\/fphar.2022.867490"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05159-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05159-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:02:17Z","timestamp":1792519337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05159-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05159-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8649506\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent to participate was obtained from the patient\u2019s legal guardian(s). Ethics approval was obtained from the Institutional Review Board of The Second Affiliated Hospital of Wannan Medical College.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of clinical details and clinical images was obtained from the patient\u2019s legal guardian(s).","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"676"}}